{
    "2020-08-31": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Alexion Stock Jumps Because Novartisâ€™ PNH Drug Might Not Be a Threat",
                "features": {
                    "keywords": [
                        "Alexion",
                        "PNH Drug",
                        "Novartis",
                        "Stock Jumps"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "The Zacks Analyst Blog Highlights: Verizon Communications, Novartis, Abbott Laboratories, AT&T, Intuitive Surgical and Northrop Grumman",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Verizon",
                        "Novartis",
                        "Abbott Laboratories",
                        "AT&T",
                        "Intuitive Surgical",
                        "Northrop Grumman"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "telecommunications",
                        "pharmaceuticals",
                        "defense"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Novartis Announces Positive Data on PNH & Cholesterol Drugs",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Positive Data",
                        "PNH",
                        "Cholesterol Drugs"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-25",
                "original_text": "Pharma Stock Roundup: AZN's Coronavirus Antibody Combo Study, & Other Updates",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "AZN",
                        "Coronavirus",
                        "Antibody Combo",
                        "Study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}